229 related articles for article (PubMed ID: 34135764)
1. Protective Effects of Sacubitril/Valsartan on Cardiac Fibrosis and Function in Rats With Experimental Myocardial Infarction Involves Inhibition of Collagen Synthesis by Myocardial Fibroblasts Through Downregulating TGF-β1/Smads Pathway.
Wu M; Guo Y; Wu Y; Xu K; Lin L
Front Pharmacol; 2021; 12():696472. PubMed ID: 34135764
[No Abstract] [Full Text] [Related]
2. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
[TBL] [Abstract][Full Text] [Related]
3. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction.
Shi YJ; Yang CG; Qiao WB; Liu YC; Liu SY; Dong GJ
Eur J Pharmacol; 2023 Dec; 961():176170. PubMed ID: 37939991
[TBL] [Abstract][Full Text] [Related]
4. [Tea Polyphenols Regulate Renin-angiotensin-aldosterone System and Transforming Growth Factor-β1/Smads Signaling Pathway in Heart Failure Rats].
Wan LF; Yuan ZJ; Chen H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):384-391. PubMed ID: 35791933
[TBL] [Abstract][Full Text] [Related]
5. Linggui Zhugan Decoction () Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Mice by Suppressing TGF-β
Wang L; Shi H; Huang JL; Xu S; Liu PP
Chin J Integr Med; 2020 May; 26(5):345-352. PubMed ID: 30623345
[TBL] [Abstract][Full Text] [Related]
6. Early Application of Sacubitril Valsartan Sodium After Acute Myocardial Infarction and its Influence on Ventricular Remodeling and TGF-β1/Smad3 Signaling Pathway.
Wang L; Zhang Y; Xue J; Da Y; Gao Y; Sun Y; Zhou S
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38290462
[TBL] [Abstract][Full Text] [Related]
7. Sacubitril/Valsartan Reduces Fibrosis and Alleviates High-Salt Diet-Induced HFpEF in Rats.
Zhang W; Liu J; Fu Y; Ji H; Fang Z; Zhou W; Fan H; Zhang Y; Liao Y; Yang T; Wang X; Yuan W; Chen X; Dong YF
Front Pharmacol; 2020; 11():600953. PubMed ID: 33519461
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
[TBL] [Abstract][Full Text] [Related]
9. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
10. Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload.
Nordén ES; Bendiksen BA; Andresen H; Bergo KK; Espe EK; Hasic A; Hauge-Iversen IM; Veras I; Hussain RI; Sjaastad I; Christensen G; Cataliotti A
ESC Heart Fail; 2021 Apr; 8(2):918-927. PubMed ID: 33497525
[TBL] [Abstract][Full Text] [Related]
11. Dengzhan Shengmai capsule attenuates cardiac fibrosis in post-myocardial infarction rats by regulating LTBP2 and TGF-β1/Smad3 pathway.
Wang M; Wang M; Zhao J; Xu H; Xi Y; Yang H
Phytomedicine; 2023 Jul; 116():154849. PubMed ID: 37163903
[TBL] [Abstract][Full Text] [Related]
12. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
13. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.
Chen X; Long L; Cheng Y; Chu J; Shen Z; Liu L; Li J; Xie Q; Liu H; Wu M; Chen Y; Peng J; Shen A
Biomed Pharmacother; 2021 May; 137():111318. PubMed ID: 33556875
[TBL] [Abstract][Full Text] [Related]
14. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice.
Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F
Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction.
Sui X; Wei H; Wang D
J Cell Mol Med; 2015 Aug; 19(8):1773-82. PubMed ID: 25823960
[TBL] [Abstract][Full Text] [Related]
16. MiR-195 promotes myocardial fibrosis in MI rats via targeting TGF-β1/Smad.
Wang DM; Jin JJ; Tian LM; Zhang Z
J Biol Regul Homeost Agents; 2020; 34(4):1325-1332. PubMed ID: 32914608
[TBL] [Abstract][Full Text] [Related]
17. Effects and mechanism of Compound Qidan Formula on rats with HFpEF induced by hypertension and diabetes mellitus based on Ang Ⅱ/TGF-β1/Smads signaling pathway.
Yuan P; Liu J; Xiong S; Yang L; Guan J; Dong G; Shi D
J Ethnopharmacol; 2023 Sep; 313():116558. PubMed ID: 37116729
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.
Zhou XL; Fang YH; Wan L; Xu QR; Huang H; Zhu RR; Wu QC; Liu JC
J Cell Physiol; 2019 Jun; 234(6):8834-8845. PubMed ID: 30317638
[TBL] [Abstract][Full Text] [Related]
19. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
20. Ling-Gui-Qi-Hua formula alleviates left ventricular myocardial fibrosis in rats with heart failure with preserved ejection fraction by blocking the transforming growth factor-β1 /Smads signaling pathway.
Shi Y; Liu C; Xiong S; Yang L; Yang C; Qiao W; Liu Y; Liu S; Liu J; Dong G
J Ethnopharmacol; 2023 Dec; 317():116849. PubMed ID: 37385575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
